CAJ | 학술논문

我国是胃癌发病率较高的国家之一，年新发病例占世界总数的42%，发病特点以进展期胃癌占大多数，复发转移率高，预后差。恶性肠梗阻是胃癌腹腔转移患者的主要临床表现之一，由于对其认知度不高，治疗水平参差不齐，许多患者未能得到有效的诊断和治疗，承受巨大的痛苦和精神压力。近年来，随着生长抑素等药物的应用，使得更多胃癌腹腔转移所致恶性肠梗阻患者的症状得到了有效的缓解，部分患者获得了化疗等抗肿瘤治疗的机会，延长了生存时间。本文就胃癌腹腔转移所致恶性肠梗阻的诊治进展及营养支持策略进行综述。
아국시위암발병솔교고적국가지일，년신발병례점세계총수적42%，발병특점이진전기위암점대다수，복발전이솔고，예후차。악성장경조시위암복강전이환자적주요림상표현지일，유우대기인지도불고，치료수평삼차불제，허다환자미능득도유효적진단화치료，승수거대적통고화정신압력。근년래，수착생장억소등약물적응용，사득경다위암복강전이소치악성장경조환자적증상득도료유효적완해，부분환자획득료화료등항종류치료적궤회，연장료생존시간。본문취위암복강전이소치악성장경조적진치진전급영양지지책략진행종술。
Gastric cancer is one of the most common types of cancer worldwide. In China, approximately 42%of new cancer cas-es are documented. However, the prognosis of advanced gastric cancer remains poor because of high recurrence and metastatic rates. In gastric cancer patients with peritoneal metastasis, malignant bowel obstruction (MBO) is often detected. Many of these patients endure excruciating pain because of ineffective diagnosis and treatment. In recent years, the symptoms of many patients with MBO have been effectively relieved after somatostatin and other drugs have been administered. Other patients with MBO have been provided the chance to undergo chemotherapy, and their survival time has been prolonged. Hence, the diagnosis and treatment of these patients could be im-proved by further advancements in basic and clinical research in cancer therapy.